Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Greenberg

Showing results (131-140 of 198) with videos related to

Pageof 20
Sort By:
American Journal of Public Health|September 2, 2003
Reestablishing public health and land use planning to protect public water suppliesMichael Greenberg, Henry Mayer, K Tyler Miller, et al.
Journal of Virology|April 14, 2004
Relative replicative fitness of human immunodeficiency virus type 1 mutants resistant to enfuvirtide (T-20)Jing Lu, Prakash Sista, Françoise Giguel, et al.
Human Vaccines & Immunotherapeutics|April 5, 2025
Health economic evaluation of implementing a universal immunization program with nirsevimab compared to standard of care for the prevention of respiratory syncytial virus disease in Canadian infantsThomas Shin, Jason Kh Lee, Alexia Kieffer, et al.
JBJS Case Connector|January 11, 2024
Distal Femoral Osteotomy for the Management of Coronal Deformity Following Total Knee Arthroplasty: A Report of 2 CasesTaylor J Reif, Michael D Greenstein, Michael Greenberg, et al.
Environmental Management|September 24, 2004
Assessing ecological resources for remediation and future land uses on contaminated landsJoanna Burger, Mary Anne Carletta, Karen Lowrie, et al.
Scientific Reports|July 3, 2020
Collective Dynamics of Model Pili-Based Twitcher-Mode BacilliformsAndrew M Nagel, Michael Greenberg, Tyler N Shendruk, et al.
Nature Reviews. Drug Discovery|March 20, 2004
Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytesTom Matthews, Miklos Salgo, Michael Greenberg, et al.
Journal of the American College of Cardiology|February 21, 2006
Beta-blockade mitigates exercise blood pressure in hypertensive male patientsPeter Kokkinos, Christina Chrysohoou, Demosthenes Panagiotakos, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|May 3, 2012
Ten most important accomplishments in risk analysis, 1980-2010Michael Greenberg, Charles Haas, Anthony Cox, et al.
Environmental Monitoring and Assessment|July 12, 2007
Factors influencing acquisition of ecological and exposure information about hazards and risks from contaminated sitesJoanna Burger, Michael Greenberg, Michael Gochfeld, et al.
Pageof 20

Showing results (131-140 of 198) with videos related to

Sort By:
Pageof 20
American Journal of Public Health|September 2, 2003
Reestablishing public health and land use planning to protect public water suppliesMichael Greenberg, Henry Mayer, K Tyler Miller, et al.
Journal of Virology|April 14, 2004
Relative replicative fitness of human immunodeficiency virus type 1 mutants resistant to enfuvirtide (T-20)Jing Lu, Prakash Sista, Françoise Giguel, et al.
Human Vaccines & Immunotherapeutics|April 5, 2025
Health economic evaluation of implementing a universal immunization program with nirsevimab compared to standard of care for the prevention of respiratory syncytial virus disease in Canadian infantsThomas Shin, Jason Kh Lee, Alexia Kieffer, et al.
JBJS Case Connector|January 11, 2024
Distal Femoral Osteotomy for the Management of Coronal Deformity Following Total Knee Arthroplasty: A Report of 2 CasesTaylor J Reif, Michael D Greenstein, Michael Greenberg, et al.
Environmental Management|September 24, 2004
Assessing ecological resources for remediation and future land uses on contaminated landsJoanna Burger, Mary Anne Carletta, Karen Lowrie, et al.
Scientific Reports|July 3, 2020
Collective Dynamics of Model Pili-Based Twitcher-Mode BacilliformsAndrew M Nagel, Michael Greenberg, Tyler N Shendruk, et al.
Nature Reviews. Drug Discovery|March 20, 2004
Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytesTom Matthews, Miklos Salgo, Michael Greenberg, et al.
Journal of the American College of Cardiology|February 21, 2006
Beta-blockade mitigates exercise blood pressure in hypertensive male patientsPeter Kokkinos, Christina Chrysohoou, Demosthenes Panagiotakos, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|May 3, 2012
Ten most important accomplishments in risk analysis, 1980-2010Michael Greenberg, Charles Haas, Anthony Cox, et al.
Environmental Monitoring and Assessment|July 12, 2007
Factors influencing acquisition of ecological and exposure information about hazards and risks from contaminated sitesJoanna Burger, Michael Greenberg, Michael Gochfeld, et al.
Pageof 20